Search

everythinglearnresearchcommunity

for

Search:↓

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Menopause can cause skin issues, and seeing a dermatologist helps.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

PCOS is linked to changes in vaginal bacteria, with fewer good bacteria and more harmful ones.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Finasteride helps hair growth but may cause sexual side effects and depression.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

Finasteride for female hair loss has low side effects, more research needed.

Finasteride and metformin both help treat PCOS, but using them together works best.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Unmarried women with PCOS in Pakistan face stigma and use various strategies to cope, needing better support and accurate information.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.